Teza Capital Management LLC Supernus Pharmaceuticals, Inc. Transaction History
Teza Capital Management LLC
- $645 Million
- Q4 2024
A detailed history of Teza Capital Management LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Teza Capital Management LLC holds 6,622 shares of SUPN stock, worth $207,798. This represents 0.04% of its overall portfolio holdings.
Number of Shares
6,622
Previous 8,898
25.58%
Holding current value
$207,798
Previous $277,000
13.72%
% of portfolio
0.04%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding SUPN
# of Institutions
303Shares Held
60.7MCall Options Held
22.3KPut Options Held
6K-
Black Rock Inc. New York, NY10.4MShares$326 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.15MShares$193 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.84MShares$152 Million2.47% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$90.3 Million0.03% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$82.5 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.68B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...